---
figid: PMC5382109__nihms824859f5
figtitle: Extrinsic and intrinsic signaling of BCR signaling activates NFKB in B-cell
  malignancies
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC5382109
filename: nihms824859f5.jpg
figlink: /pmc/articles/PMC5382109/figure/F5/
number: F5
caption: Extrinsic and intrinsic signaling of BCR signaling activates NF-κB in B-cell
  malignancies. a, In ABC-DLBCL, ITAM, CARD11, and MYD88 independence of BCR. b, In
  CLL, L265 MYD88 mutation and RelB activation. c, In MALT, overexpression of BCL10
  or MALT1 fusion protein. d, In HL, EBV, CD30 and Notch1.
papertitle: NF-κB Signaling Pathway and its Potential as a Target for Therapy in Lymphoid
  Neoplasms.
reftext: Li Yu, et al. Blood Rev. ;31(2):77-92.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5961283
figid_alias: PMC5382109__F5
figtype: Figure
redirect_from: /figures/PMC5382109__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5382109__nihms824859f5.html
  '@type': Dataset
  description: Extrinsic and intrinsic signaling of BCR signaling activates NF-κB
    in B-cell malignancies. a, In ABC-DLBCL, ITAM, CARD11, and MYD88 independence
    of BCR. b, In CLL, L265 MYD88 mutation and RelB activation. c, In MALT, overexpression
    of BCL10 or MALT1 fusion protein. d, In HL, EBV, CD30 and Notch1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ABCB6
  - BCR
  - RN7SL263P
  - BCL10
  - MYD88
  - CARD11
  - MALT1
  - TNFRSF8
  - RELB
  - CD2
  - NFKB1
  - bcr
  - bcl10
  - myd88
  - card11
  - malt1
  - malt2
  - relb
---
